Access Purchased Content

The Carlat Child Psychiatry Report

Evidence-Based Treatment in Child and Adolescent Psychiatry | 2026

View Archived Issues

Learning Objectives, Evidence-Based Treatment in Child and Adolescent Psychiatry, CCPR, April/May/June 2026

April 2, 2026

After reading these articles, you should be able to… 

Read More

What Works in Child and Adolescent Psychiatry: A Guide to Evidence-Based Treatments

April 1, 2026
Elizabeth Steuben, MD

When treatment options feel overwhelming, evidence is your anchor.  

Read More

Assessing the Evidence in Child and Adolescent Psychiatry

May 8, 2026
Glen Spielmans, PhD.

Not all studies are created equal — and in child psychiatry, the stakes of getting it wrong are high. Dr. Spielmans introduces the PICOT framework, exposes common sources of bias in clinical trials, and offers practical tools for vetting the research before it reaches your patients.

Read More

New Antipsychotic Formulations for Children and Adolescents: Caution Prevails

April 1, 2026
Rebecca F. Young, MD and Max S. Rosen, MD

Newer antipsychotics promise novel mechanisms and fewer metabolic headaches, but the pediatric data have not caught up with the enthusiasm. This update cuts through the excitement around lumateperone, xanomeline-trospium, and TAAR1 agonists, and offers a practical framework for deciding when, if ever, to venture beyond the tried-and-true SGAs.

Read More

A Three-Question Scale Offers a Quick Read on Antidepressant Side Effects in Youth

April 1, 2026
Joshua Feder, MD

Side effects are the most common reason kids stop antidepressants, yet most monitoring tools are too cumbersome for real-world visits. The FIBSER-C asks just three questions and takes under a minute. Could this be the side effect check-in your practice has been missing?

Read More

SSRIs May Slow Height Gain

April 1, 2026
Joshua Feder, MD

SSRIs are among the most prescribed medications in adolescents, but are we paying close enough attention to what they may be doing to pubertal growth? A prospective cohort study found dose-related reductions in height velocity, with changes in growth hormone signaling suggesting a possible biologic mechanism.

Read More

SSRIs Help Modestly With Pediatric OCD

May 8, 2026
Joshua Feder, MD

SSRIs are standard for pediatric OCD, but how much do they actually move the needle? An individual participant data meta-analysis puts a number on it, and the answer is more nuanced than the guidelines suggest. Baseline severity, it turns out, matters more than most clinicians realize.

Read More

Low-Dose Aripiprazole for Youth With Anorexia

April 1, 2026
Joshua Feder, MD

When family-based therapy stalls in adolescents with anorexia, what comes next? A retrospective matched-cohort study suggests that low-dose aripiprazole may loosen cognitive rigidity enough to get treatment moving again — with doses averaging under 3 mg/day and a surprisingly favorable side-effect profile.

Read More

CME Post-Test, Evidence-Based Treatment in Child and Adolescent Psychiatry, CCPR, April/May/June 2026

April 1, 2026

By successfully completing the test you will be awarded a certificate for 2 CME credits.

Read More
Featured Book
Featured Video
Featured Podcast
Recommended

About

Shop Online

Newsletters

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.